CYT-108 is under development for treatment of osteoarthritis. The drug candidate is a endogenous recombinant alpha-2 macroglobulin (A2M). It is administered through intraarticular route. Cytonics is ...

MK-6837 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Detailed price information for Troilus Gold Corp (TLG-T) from The Globe and Mail including charting and trades.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

The global semiconductor industry is making headlines, fuelled by surging demand for electronic devices and groundbreaking ...

Struggling with automated bidding on Google Ads? Learn practical insights to improve campaign performance and control costs.

Brent is also at the heart of a number of proposed changes by Transport for London (TfL), including the creation of a new ...

The S&P 500's returns are measured using time-weighted returns (TWR), which don't account for cash flows like withdrawals. If you're retired and withdrawing funds, comparing your portfolio to the S&P ...

When Gloria Kopp got fed up with diet after diet that just didn't work, she took the advice of a friend who'd slimmed down with a commercial diet plan called the Medi-Weightloss Program.

The core HR software market is projected to expand at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period ...

THISDAY has honoured D’Tigress as Sports Personality of the Year and unveiled nominees for Game Changer and Lifetime Achievements categories ...